inversago pharma inc logo

Inversago Pharma Inc

Inversago Pharma develops peripherally restricted, orally administered CB1R inverse agonists, to treat metabolic disorders.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://inversago.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
6387 Louis-Hemon St. H2G 2K8
Montreal
Canada
Email
info@inversago.com
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/inversago-pharma-inc” connections=”true” suffix=””]